Jason Ding, FCPA, FCA

Chief Business Officer at Entos Pharmaceuticals

Jason Ding, FCPA, FCA has a diverse work experience in various industries and roles. Jason is currently serving as the Chief Business Officer at Entos Pharmaceuticals since March 2022. Previously, Jason held the position of Board of Directors at TELUS World of Science - Edmonton from April 2016 to May 2023.

Jason has an extensive background in finance and consulting. Jason worked at Deloitte Canada, where they held multiple leadership positions. From June 2019 to February 2022, they served as the Partner and Senior Managing Director of Deloitte Corporate Finance. Additionally, they held the role of National Life Science & Healthcare Financial Advisory Leader during the same period. Prior to that, they were the Managing Director and Edmonton Corporate Finance Leader from February 2017 to June 2019.

In the life science industry, Jason has valuable experience serving on boards and directors. Jason was a Board of Directors member at CELS - Canadian Entrepreneurs in Life Science from 2018 to 2021. Jason also served as a Board Director at VaxAlta, Inc. from 2014 to December 2019. Furthermore, they held the position of Supervisory Board Director at Temple Therapeutics BV from 2016 to 2018.

Jason's involvement in various organizations extended beyond finance and life science. Jason served as a Board Director at Edmonton Economic Development Corporation from April 2016 to 2017. Moreover, they held the role of Program Director at TEC Edmonton, where they were responsible for the TEC Health Accelerator program and acted as an Executive-in-Residence from 2011 to 2017.

Additionally, Jason founded and managed H2 Technology Consulting Inc. from 2011 to 2017. Prior to that, they worked at CPA Western School of Business, where they served as a Contractor. Jason facilitated e-learning modules for CA students, graded assignments, facilitated online discussions, and provided feedback from September 2006 to December 2015.

Overall, Jason Ding has built a significant professional background through their leadership roles, board memberships, and expertise in finance and consulting.

Jason Ding, FCPA, FCA has an extensive education history. In 1997, they began their academic journey at the University of Alberta, where they pursued a Bachelor of Science degree in Biological Sciences with a focus on Genetics. Jason completed this degree in 2002.

In the same year, Jason also obtained a Conflict Management Certificate from the ADR Institute of Alberta. This certification equipped him with skills in interest-based mediation and negotiation.

Continuing their education, Jason enrolled at the Chartered Professional Accountants of Canada (CPA Canada) in 2004. Jason successfully obtained the Chartered Accountant Designation and became a member of CPA Canada in 2007.

Driven by their passion for business valuation, Jason decided to pursue the CBV Designation at the Canadian Institute of Chartered Business Valuators. Jason studied there from 2007 to 2009, gaining expertise in this field.

Furthermore, Jason focused on enhancing their leadership and innovation skills. In 2019, they attended the adMare Academy Executive Institute, where they completed an Executive Institute program in Leadership in Innovation.

Jason's commitment to continuous learning is evident through their involvement with the Institute of Corporate Directors. In 2015, they pursued the ICD.D Designation, which emphasizes corporate governance, ethical decision-making, and strategic leadership.

In terms of additional certifications, Jason obtained the prestigious FCPA, FCA designation from CPA Alberta, showcasing their high level of expertise and professionalism in the accounting profession. Jason achieved this certification in March 2020. Jason also holds certifications such as CBV from The Canadian Institute of Chartered Business Valuators and ICD.D from the Institute of Corporate Directors, although the specific details of these certifications are not provided.

Links

Previous companies

Deloitte logo

Timeline

  • Chief Business Officer

    March, 2022 - present